Devers Shannon L.

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Devers Shannon L.'s trades of Ionis Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
79.50
Quantity 39,014
Value US$3,101,613
Transaction date
Proposed sale
Price
81.34
Quantity 3,977
Value US$323,490
Transaction date
Proposed sale
Price
81.34
Quantity 3,977
Value US$323,490
Transaction date
Proposed sale
Price
76.22
Quantity 8,353
Value US$636,626
Transaction date
Proposed sale
Price
84.68
Quantity 9,390
Value US$795,117
Transaction date
Proposed sale
Price
80.91
Quantity 42,322
Value US$3,424,273
Transaction date
Proposed sale
Price
75.00
Quantity 15,670
Value US$1,175,250
Transaction date
Proposed sale
Price
61.02
Quantity 3,162
Value US$192,958
Transaction date
Proposed sale
Price
32.70
Quantity 4,267
Value US$139,531
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-02 2026-04-02
PlS Planned sale
35,578 +25.3%
300.93
US$4,126,565 		35,578 +25.3% 300.93 US$4,126,565
2026-03-05 2026-03-03
PlS Planned sale
19,926 -14.6%
459.83
US$3,791,046 		19,926 -14.6% 459.83 US$3,791,046
2026-03-05 2026-03-03
PlS Planned sale
64,129 +16.5%
435.64
US$3,466,977 		64,129 +16.5% 435.64 US$3,466,977
2026-03-05 2026-03-03
PlS Planned sale
14,321 -33.6%
79.12
US$1,133,006 		14,321 -33.6% 79.12 US$1,133,006
2026-03-03 2026-03-03
PrS Proposed sale
39,014
79.50
US$3,101,613 		39,014 79.50 US$3,101,613
2026-01-23 2026-01-22
PrS Proposed sale
3,977
81.34
US$323,490 		3,977 81.34 US$323,490
2026-01-23 2026-01-22
PlS Planned sale
3,977 -15.0%
81.34
US$323,490 		3,977 -15.0% 81.34 US$323,490
2026-01-22 2026-01-22
PrS Proposed sale
3,977
81.34
US$323,490 		3,977 81.34 US$323,490
2026-01-20 2026-01-16
S Sale
8,353 -24.0%
75.95
US$634,410 		8,353 -24.0% 75.95 US$634,410
2026-01-16 2026-01-16
PrS Proposed sale
8,353
76.22
US$636,626 		8,353 76.22 US$636,626
2026-01-09 2026-01-07
PlS Planned sale
9,264 -34.6%
84.62
US$783,920 		9,264 -34.6% 84.62 US$783,920
2026-01-09 2026-01-07
PlS Planned sale
3,829 -18.0%
84.62
US$324,010 		3,829 -18.0% 84.62 US$324,010
2026-01-09 2026-01-07
PlS Planned sale
3,460 -16.5%
84.62
US$292,785 		3,460 -16.5% 84.62 US$292,785
2026-01-09 2026-01-07
PlS Planned sale
2,101 -10.7%
85.36
US$179,341 		2,101 -10.7% 85.36 US$179,341
2026-01-09 2026-01-07
PlS Planned sale
25,545 -59.4%
85.36
US$2,180,521 		25,545 -59.4% 85.36 US$2,180,521
2026-01-07 2026-01-07
PrS Proposed sale
9,390
84.68
US$795,117 		9,390 84.68 US$795,117
2025-11-28 2025-11-25
PlS Planned sale
16,777 -49.0%
80.91
US$1,357,442 		16,777 -49.0% 80.91 US$1,357,442
2025-11-25 2025-11-25
PrS Proposed sale
42,322
80.91
US$3,424,273 		42,322 80.91 US$3,424,273
2025-10-16 2025-10-16
S Sale
1,263 -6.7%
73.62
US$92,984 		1,263 -6.7% 73.62 US$92,984
2025-10-16 2025-10-15
PlS Planned sale
6,000 -27.4%
72.94
US$437,654 		6,000 -27.4% 72.94 US$437,654
2025-10-15 2025-10-15
PrS Proposed sale
15,670
75.00
US$1,175,250 		15,670 75.00 US$1,175,250
2025-09-04 2025-09-03
PlS Planned sale
3,162 -17.4%
61.02
US$192,943 		3,162 -17.4% 61.02 US$192,943
2025-09-03 2025-09-03
PrS Proposed sale
3,162
61.02
US$192,958 		3,162 61.02 US$192,958
2025-01-17 2025-01-16
S Sale
4,267 -21.1%
32.78
US$139,855 		4,267 -21.1% 32.78 US$139,855
2025-01-16 2025-01-16
PrS Proposed sale
4,267
32.70
US$139,531 		4,267 32.70 US$139,531